BRAF and breast cancer: The post-BC ctDNA BRAF AV detection rate was significantly higher in non-responders compared to responders (p = 0.02), and further, BRAF AV status (positive/negative) associated with significantly worse OS (median OS, 13.0 and 30.6 months, respectively; p = 0.039).